Conavi medical announces results from its annual general meeting of shareholders and adoption of amendments to omnibus equity incentive plan

Toronto, april 01, 2025 (globe newswire) -- conavi medical corp. (tsxv: cnvi; otcqb: cnvif) (“conavi medical” or the “company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, announced today the results of its annual general meeting of shareholders held virtually on march 31, 2025 (the “meeting”), as well as the adoption of amendments to the company's stock option plan.
GM Ratings Summary
GM Quant Ranking